Sunshine Biopharma Inc (NASDAQ: SBFM) on Friday, plunged -5.09% from the previous trading day, before settling in for the closing price of $0.44. Within the past 52 weeks, SBFM’s price has moved between $0.28 and $64.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 542.96%. The company achieved an average annual earnings per share of 99.95%. With a float of $18.90 million, this company’s outstanding shares have now reached $18.95 million.
The extent of productivity of a business whose workforce counts for 44 workers is very important to gauge.
Sunshine Biopharma Inc (SBFM) Insider and Institutional Ownership
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Sunshine Biopharma Inc is 0.22%, while institutional ownership is 0.78%. The most recent insider transaction that took place on Mar 04 ’24, was worth 10,000. In this transaction Chief Executive Officer of this company bought 100,000 shares at a rate of $0.10, taking the stock ownership to the 130,000 shares. Before that another transaction happened on Feb 08 ’24, when Company’s Chief Executive Officer bought 20,000 for $0.10, making the entire transaction worth $2,000. This insider now owns 30,000 shares in total.
Sunshine Biopharma Inc (SBFM) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 99.95% per share during the next fiscal year.
Sunshine Biopharma Inc (NASDAQ: SBFM) Trading Performance Indicators
Sunshine Biopharma Inc (SBFM) is currently performing well based on its current performance indicators. A quick ratio of 3.23 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -13.33, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach 0.60 in one year’s time.
Technical Analysis of Sunshine Biopharma Inc (SBFM)
The latest stats from [Sunshine Biopharma Inc, SBFM] show that its last 5-days average volume of 2.49 million was superior to 2.24 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 80.07%. Additionally, its Average True Range was 0.14.
During the past 100 days, Sunshine Biopharma Inc’s (SBFM) raw stochastic average was set at 0.53%, which indicates a significant decrease from 72.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 293.58% in the past 14 days, which was lower than the 305.31% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7712, while its 200-day Moving Average is $16.4741. Now, the first resistance to watch is $0.4544. This is followed by the second major resistance level at $0.4912. The third major resistance level sits at $0.5225. If the price goes on to break the first support level at $0.3863, it is likely to go to the next support level at $0.3550. The third support level lies at $0.3182 if the price breaches the second support level.
Sunshine Biopharma Inc (NASDAQ: SBFM) Key Stats
Market capitalization of the company is 7.91 million based on 18,945K outstanding shares. Right now, sales total 24,090 K and income totals -4,510 K. The company made 7,540 K in profit during its latest quarter, and -1,280 K in sales during its previous quarter.
